Join the Thyroid Cancer group to help and get support from people like you.
Thyroid Cancer News (Page 2)
Related terms: Anaplastic thyroid cancer
FDA Approves Lenvima (lenvatinib) for Differentiated Thyroid Cancer
February 13, 2015 – The U.S. Food and Drug Administration today granted approval to Lenvima (lenvatinib) to treat patients with progressive, differentiated thyroid cancer (DTC) whose disease...
FDA Approves Nexavar to Treat Metastatic Differentiated Thyroid Cancer
November 22, 2013 – The U.S. Food and Drug Administration today expanded the approved uses of Nexavar (sorafenib) to treat late-stage (metastatic) differentiated thyroid cancer. Thyroid cancer is...
FDA Approves Cometriq (cabozantinib) to Treat Rare Type of Thyroid Cancer
November 29, 2012 – The U.S. Food and Drug Administration today approved Cometriq (cabozantinib) to treat medullary thyroid cancer that has spread to other parts of the body (metastasized). ...
FDA Approves Orphan Drug Vandetanib for Advanced Medullary Thyroid Cancer
WILMINGTON, Del.--(BUSINESS WIRE)--Apr 6, 2011 - AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) approved the orphan drug vandetanib for the treatment of medullary...